Bartlett & Co Wealth Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
Other funds holding IHE
Bartlett & Co Wealth Management's IHE Position: Q3 2026 in Review
Bartlett & Co Wealth Management held its iShares US Pharmaceuticals ETF (IHE) position steady in Q3 2026 at 90 shares worth $9.05K. The position accounts for ﹤0.01% of the portfolio, ranked #1026.
Bartlett & Co Wealth Management first reported a position in IHE in Q1 2018 and has held it in 34 quarters since. 245 funds tracked by Wall St. Rank hold IHE as of Q3 2026.
- Bartlett & Co Wealth Management held 90 shares of iShares US Pharmaceuticals ETF worth $9.05K as of Q3 2026.
- Bartlett & Co Wealth Management left its iShares US Pharmaceuticals ETF share count unchanged in Q3 2026.
- iShares US Pharmaceuticals ETF made up ﹤0.01% of Bartlett & Co Wealth Management's portfolio in Q3 2026, its #1026 holding.
- Bartlett & Co Wealth Management first reported a position in iShares US Pharmaceuticals ETF in Q1 2018 and has held it in 34 quarters since.
- 245 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2026.
Based on Bartlett & Co Wealth Management's 13F filing for Q3 2026, filed 12 Nov 2026.